Dr. Immanuel Lerner, Pepticom’s CEO, will present at “DISCOVERY on TARGET” Conference in Boston (September 25-28).

Dr. Lerner will discuss Pepticom’s exciting design work on TLR4 activators in “the Cyclic Peptide Design Challenges” session.

Skip to content